Innovative Grade US Origin Swine Whole

Innovative Grade US Origin Swine Whole 

To Order Contact us: lieven@wlsolutions.be

Fetal Bovine Serum (FBS), Premium, 100% US Origin
P760-10 NULL
EUR 0

Fetal Bovine Serum (FBS), Premium, 100% US Origin
P760S NULL
EUR 0

Fetal Bovine Serum (FBS), Premium, 100% US Origin, ESC Tested
P761-1 NULL
EUR 0

Fetal Bovine Serum (FBS), Premium, 100% US Origin, ESC Tested
P761-10 NULL
EUR 0

Fetal Bovine Serum (FBS), Premium, 100% US Origin, ESC Tested
P761S NULL
EUR 0

L-Tyrosine, USP grade, non-animal origin
GM1911-1KG 1 kg
EUR 309

L-Tyrosine, USP grade, non-animal origin
GM1911-500G 500 g
EUR 174

L-Glutamine, USP grade, non-animal origin
GM2001-1KG 1 kg
EUR 309

Chondroitin sulfate, from bovine origin, USP grade
GC3554-50G 50 g
EUR 181

Swine-Origin and Seasonal Flu H1N1 Protein Detection Set
PSI-1829 1 Set
EUR 1188.5
  • Optimal dilutions for each application to be determined by the researcher.
Description: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin (4). The distinct antigenic properties of the new swine virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups (5). Antibodies #5235 and 5239 are specific for the seasonal H1N1 influenza Hemagglutinin and will not recognize the corresponding Hemagglutinin sequence from the swine-origin H1N1 influenza (A/California/14/2009 (H1N1)). Similarly, antibodies #5237 and #5241 are specific for the swine-origin H1N1 influenza Hemagglutinin and will not recognize the seasonal H1N1 Hemagglutinin (A/Brisbane/59/2007 (H1N1). The Neuraminidase antibodies #5247 and #5249 are specific for seasonal and swine-origin H1N1 influenza Neuraminidase, respectively.;;For images please see PDF data sheet

Insulin-US Standard F
F282F 1 ml
EUR 195
  • Product category: Quality control/standard for molecular biology applications
Description: Insulin-US Standard F by Cygnus Technologies is available in Europe via Gentaur.

Chitin, fungal origin
GC8934-1KG 1 kg
EUR 184

Chitin, fungal origin
GC8934-250G 250 g
EUR 81

Chitin, fungal origin
GC8934-500G 500 g
EUR 118

Goat Swine IgG
A21090-01ml 0.1ml
EUR 77
  • Immunogen information: Swine IgG whole molecule
  • Applications tips:
Description: A polyclonal antibody for detection of Goat Swine IgG from Swine. This Goat Swine IgG antibody is for WB, IHC-P, ELISA. It is Affinity purified using solid phase Swine IgG (H&L) with finally > 95% purity based on SDS-PAGE and conjugated to HRP. The antibody is produced in goat by using as an immunogen Swine IgG whole molecule

Goat Swine IgG
A21090-05ml 0.5ml
EUR 158
  • Immunogen information: Swine IgG whole molecule
  • Applications tips:
Description: A polyclonal antibody for detection of Goat Swine IgG from Swine. This Goat Swine IgG antibody is for WB, IHC-P, ELISA. It is Affinity purified using solid phase Swine IgG (H&L) with finally > 95% purity based on SDS-PAGE and conjugated to HRP. The antibody is produced in goat by using as an immunogen Swine IgG whole molecule

Swine Albumin Antibody
12004-05011 150 ug
EUR 217

Swine Haptoglobin Antibody
15771-05011 150 ug
EUR 217

Swine Elastase Antibody
20271-05011 150 ug
EUR 217

Swine Prothrombin Antibody
25887-05011 150 ug
EUR 217

Mannide monooleate, animal origin
GC1955-100G 100 g
EUR 181

Mannide monooleate, animal origin
GC1955-25G 25 g
EUR 90

Cholesterol, non-animal origin
GE7110-1G 1 g
EUR 229

Insulin-US Standards Set, A-F
F282 1 ml
EUR 488
  • Product category: Quality control/standard for molecular biology applications
Description: Insulin-US Standards Set, A-F by Cygnus Technologies is available in Europe via Gentaur.

PIPET CONTROLLER BATTERY COVER (US VERSION)
357487 1/pk
EUR 44
Description: Falcon Liquid Handling Equipment; Falcon Pipet Controllers and Accessories

Histone (Whole) Antibody
abx023918-2ml 2 ml
EUR 509
  • Shipped within 5-10 working days.

Rat Whole Heart
PC35133 P0 Rat - Whole Heart X2
EUR 1341

Mouse Whole Heart
PC35135 P0 Mouse - Whole heart X2
EUR 1341

Swine Swine Fever Virus Antibody (CSFV-Ab) ELISA Kit
abx364798-96tests 96 tests
EUR 543
  • Shipped within 5-12 working days.

Hyaluronidase Grade I (Molecular Biology Grade)
CE174 1 g
EUR 194

Hyaluronidase Grade I (Molecular Biology Grade)
CE175 5 g
EUR 767

Mini Dry Bath, 100-240V (US Plug)
BCM1405 1 pcs, 1 UNIT
EUR 394.57
  • Product category: Benchtop Equipment/Heat Baths/Dry Baths

12 Mini Centrifuge 100-240V (US plug)
BCM1746 1 pcs, 1 UNIT
EUR 567.12
  • Product category: Benchtop Equipment/Centrifuges/Mini

ProPette Pipette Controller, w/ QuickStand, 115V US
P6080 1/pack
EUR 230.9
Description: ProPette Pipette Controller w/ QuickStand

alpha-Amanitin - fungal fermentation origin
ADC-P-107 unit Ask for price

Calcium stearate, non-animal origin
GK5845-1KG 1 kg
EUR 86

Calcium stearate, non-animal origin
GK5845-5KG 5 kg
EUR 225

L-Cystine, non-animal origin
GM2911-100G 100 g
EUR 78

L-Cystine, non-animal origin
GM2911-1KG 1 kg
EUR 320

L-Cystine, non-animal origin
GM2911-250G 250 g
EUR 125

L-Cystine, non-animal origin
GM2911-500G 500 g
EUR 196

Chondroitin sulfate, from bovine origin
GC0982-1G 1 g
EUR 43

Chondroitin sulfate, from bovine origin
GC0982-25G 25 g
EUR 75

Chondroitin sulfate, from bovine origin
GC0982-50G 50 g
EUR 110

Chondroitin sulfate, from bovine origin
GC0982-5G 5 g
EUR 52

Endothelin 1 (swine, human)
HY-P0202 500ug
EUR 215

Swine CCL2 Recombinant Protein
R00056-5 5ug/vial
EUR 259
Description: Chemokine (C-C motif) ligand 2 (CCL2), also known as monocyte chemotactic protein-1 (MCP-1), is a small cytokine belonging to the CC chemokine family. CCL2 (MCP-1) recruits monocytes, memory T cells, and dendritic cells to sites of tissue injury and infection. Swine CCL2 (MCP-1) Recombinant Protein is purified CCL2 (MCP-1) produced in yeast.

Swine CXCL10 Recombinant Protein
R00278-8 5ug/vial
EUR 259
Description: The ELR-negative CXC chemokine CXCL10 (IP-10) has been attributed to several roles, such as chemoattraction for monocytes/macrophages, T cells, NK cells, and dendritic cells, promotion of T cell adhesion to endothelial cells, antitumor activity, and inhibition of bone marrow colony formation and angiogenesis. Swine CXCL10 Recombinant Protein is purified CXCL10 (IP-10) produced in yeast.

Swine EPO Recombinant Protein
R00484-2 5ug/vial
EUR 259
Description: Erythropoietin (EPO) is an essential hormone for red blood cell production. Erythropoietin has a range of actions including vasoconstriction-dependent hypertension, stimulating angiogenesis, and inducing proliferation of smooth muscle fibers. Swine Erythropoietin Recombinant Protein is purified Erythropoietin (EPO) produced in yeast.

Swine CCL5 Recombinant Protein
R00617-4 5ug/vial
EUR 259
Description: CCL5, also known as RANTES (regulated and normal T cell expressed and secreted), is a member of the C-C Chemokine Family. RANTES (CCL5) is chemotactic for T cells, eosinophils, and basophils, and plays an active role in recruiting leukocytes into inflammatory sites. Swine CCL5 Recombinant Protein is purified CCL5 (RANTES) produced in yeast.

Swine CCL4 Recombinant Protein
R00703-7 5ug/vial
EUR 259
Description: The small chemotactic cytokine CCL4 (MIP-1 beta) is a chemoattractant for natural killer cells, monocytes and a variety of other immune cells. CCL4 is involved in several inflammatory and autoimmune diseases including viral infection such as HIV-1/AIDS. Swine CCL4 Recombinant Protein is purified chemokine ligand 4 (CCL4, MIP-1 beta) produced in yeast.

Swine CCL20 Recombinant Protein
R00748-1 5ug/vial
EUR 259
Description: Chemokine ligand 20 (CCL20), also known as liver activation regulated chemokine (LARC) or Macrophage Inflammatory Protein-3 (MIP3A), is strongly chemotactic for lymphocytes. CCL20 elicits its effects on its target cells by binding and activating the chemokine receptor CCR6. Swine CCL20 Recombinant Protein is purified CCL20 (LARC, MIP3A) produced in yeast.

Swine CD40LG Recombinant Protein
R01114-2 5ug/vial
EUR 259
Description: CD40 Ligand (CD40LG) is a transmembrane protein that is a member of the TNF superfamily. In addition to existing in a membrane bound form, CD40LG can also be released as a soluble molecule (sCD40LG), which has been shown to have biological functions.CD40 interacts with CD40 ligand (aka CD40LG, TNFSF5 or CD154), which is predominantly expressed on activated CD4+ T-cells. Swine CD40 Ligand Recombinant Protein is purified CD40LG produced in yeast.

Swine BAFF Recombinant Protein
R01257-5 5ug/vial
EUR 259
Description: BAFF (B-cell Activation Factor), also known as Tumor Necrosis Factor Superfamily member 13B (TNFSF13B), is expressed in B cell lineage cells and acts as a potent B cell activator. It has been also shown to play an important role in the proliferation and differentiation of B cells. Swine BAFF Recombinant Protein is purified b-cell activation factor produced in yeast.

Swine CXCL9 Recombinant Protein
R01397-6 5ug/vial
EUR 259
Description: CXCL9 (MIG) is a T-cell chemoattractant. Induced by IFN-gamma (IFN-γ), the ELR-negative chemokine CXCL9 (MIG) elicits its effects by binding to the cell surface chemokine receptor CXCR3. Swine CXCL9 Recombinant Protein is purified CXCL9 (MIG) produced in yeast.

Swine CXCL11 Recombinant Protein
R01833-1 5ug/vial
EUR 259
Description: Chemokine (C-X-C motif) ligand 11 (CXCL11) is a small, interferon-inducible cytokine belonging to the CXC chemokine family. Along with homologous ELR-negative CXC chemokines CXCL9 (MIG) and CXCL10 (IP-10), CXCL11 facilitates selective recruitment of mononuclear leukocytes, natural killer cells, and plasmacytoid dendritic cells to sites of inflammation. Swine CXCL11 Recombinant Protein is purified CXCL11 produced in yeast.

Swine TWEAK Recombinant Protein
R02009-1 5ug/vial
EUR 259
Description: TNF-related weak inducer of apoptosis (TWEAK) is a member of the tumor necrosis factor (TNF) ligand family (TNFSF12). TWEAK can induce apoptosis via multiple pathways of cell death in a cell type-specific manner. TWEAK is also found to promote proliferation and migration of endothelial cells, and thus acts as a regulator of angiogenesis. Swine TWEAK (TNFSF12) Recombinant Protein is purified TWEAK (TNFSF12) produced in yeast.

Swine APRIL Recombinant Protein
R02417-5 5ug/vial
EUR 259
Description: A proliferation-inducing ligand (APRIL), also known as TNFSF13, is a member of the tumor necrosis factor (TNF) ligand superfamily. APRIL/TNFSF13 has been shown to play a role in protecting cells from undergoing apoptosis and promoting B cell development. Swine APRIL Recombinant Protein is purified APRIL (TNFSF13) produced in yeast.

Swine CCL3L1 Recombinant Protein
R11820 5ug/vial
EUR 259
Description: CCL3L1, Chemokine (C-C motif) Ligand 3-Like 1, binds to several chemokine receptors including chemokine binding protein 2 (CCBP2) and CC chemokine receptor 5 (CCR5). Swine CCL3L1 Recombinant Protein is purified chemokine (C-C motif) ligand 3-like 1 produced in yeast.

Swine/Rat Galanin Antibody
10881-05011 150 ug
EUR 217

Swine H1N1 Hemagglutinin Antibody
24918-100ul 100ul
EUR 390

Swine H1N1 Hemagglutinin Antibody
24920-100ul 100ul
EUR 390

Swine H1N1 Hemagglutinin Antibody
24922-100ul 100ul
EUR 390

Swine H1N1 Neuraminidase Antibody
24925-100ul 100ul
EUR 390

Swine H1N1 Hemagglutinin Antibody
5233-002mg 0.02 mg
EUR 171.82
  • Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Description: Swine H1N1 Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups. This antibody is specific for the novel swine influenza Hemagglutinin and will not recognize the corresponding Hemagglutinin sequence from the seasonal H1N1 influenza (A/Brisbane/59/2007 (H1N1)).

Swine H1N1 Hemagglutinin Antibody
5233-01mg 0.1 mg
EUR 436.42
  • Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Description: Swine H1N1 Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups. This antibody is specific for the novel swine influenza Hemagglutinin and will not recognize the corresponding Hemagglutinin sequence from the seasonal H1N1 influenza (A/Brisbane/59/2007 (H1N1)).

Swine H1N1 Hemagglutinin Antibody
5237-002mg 0.02 mg
EUR 171.82
  • Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Description: Swine H1N1 Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.

Swine H1N1 Hemagglutinin Antibody
5237-01mg 0.1 mg
EUR 436.42
  • Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Description: Swine H1N1 Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.

Swine H1N1 Hemagglutinin Antibody
5241-002mg 0.02 mg
EUR 171.82
  • Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Description: Swine H1N1 Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine influenza virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.

Swine H1N1 Hemagglutinin Antibody
5241-01mg 0.1 mg
EUR 436.42
  • Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Description: Swine H1N1 Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine influenza virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.

Swine H1N1 Neuraminidase Antibody
5249-002mg 0.02 mg
EUR 171.82
  • Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Description: Swine H1N1 Neuraminidase Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine influenza virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.

Swine H1N1 Neuraminidase Antibody
5249-01mg 0.1 mg
EUR 436.42
  • Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Description: Swine H1N1 Neuraminidase Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine influenza virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.

Swine H1N1 Hemagglutinin Peptide
5233P 0.05 mg
EUR 164.75
Description: Swine H1N1 Hemagglutinin peptide

Swine H1N1 Hemagglutinin Peptide
5237P 0.05 mg
EUR 164.75
Description: Swine H1N1 Hemagglutinin peptide

Swine H1N1 Hemagglutinin Peptide
5241P 0.05 mg
EUR 164.75
Description: Swine H1N1 Hemagglutinin peptide

Swine H1N1 Neuraminidase Peptide
5249P 0.05 mg
EUR 164.75
Description: Swine H1N1 Neuraminidase peptide

electrophoresis ps 400v, 500ma, 50w
EV1450-US ea
EUR 479

electrophoresis ps 1500v, 300ma, 150w
EV2230-US ea
EUR 749

electrophoresis ps 300v, 1000ma, 150w
EV2310-US ea
EUR 572

electrophoresis ps 3000v, 150ma, 150w
EV2320-US ea
EUR 749

Innovative Grade US Origin Swine Whole